9/11 Survivors Now Outnumber First Responders in Cancer Cases — And the Government Is Failing Them
For the first time, cancer cases among 9/11 civilian survivors have surpassed those of first responders, a shift that exposes a flawed eligibility system leaving thousands without care. Only 15% of exposed civilians are enrolled in the health program.
The Forgotten Survivors Are Now the Tallest Order
The number of cancer certifications among 9/11 civilian survivors has passed the number for first responders for the first time — a quiet statistical milestone that marks a seismic shift in one of the worst environmental health disasters in American history.
By this year, survivors accounted for 28,913 cancer cases under the World Trade Center Health Program, compared with 28,131 among firefighters, police officers, and other emergency responders. That means, roughly, that the people who ran into the smoke were no longer the ones bearing the heaviest cancer burden from that day. The people who stayed behind — and lived — were taking over.
Survivor cancer certifications alone have surged 4,066% since 2015, rising from 694 to 28,913. Overall certifications across the program climbed from 3,204 to 57,044 in the same period — a 1,680% increase, according to program data. The math is blunt: nearly two people are dying from 9/11-related illnesses every single day, and a new cancer certification rolls in every 50 minutes.
Rare Cancers Are the Tell
What makes this crisis distinct from ordinary cancer epidemiology is the shape of the disease. The cancers appearing at elevated rates among survivors are the ones that usually barely register on any radar.
Eighty-two cases of thymus gland cancer have been recorded. That organ, sitting behind the breastbone, produces tumors that account for fewer than 1% of all malignancies. Five hundred ninety-one neuroendocrine cancers — uncommon tumors of the pancreas, bowel, lungs, or adrenal glands — have been certified. In a single quarter, that neuroendocrine figure jumped 6% among survivors.
One hundred eighty-eight men have been diagnosed with breast cancer. One hundred sixty-three have developed brain cancer — and that number rose 9% in just the past three months.
These are not the cancers you expect from aging alone. They are the cancers you expect when people breathe in pulverized concrete, glass, asbestos, and synthetic fibers at ground zero and then are told the air is safe.
The Eligibility System Was Built for a Narrative That No Longer Fits
The World Trade Center Health Program was created in 2006 to serve first responders and recovery workers — the people who went into the disaster zone. Civilians who lived or worked near Ground Zero were largely left out, included only through subsequent legislative expansions that came years later and often required people to prove they had been within certain zones during certain timeframes.
That framework assumed a specific picture of exposure: boots on the ground, shovels in hand, suits respirators strapped to faces. It did not assume the paralegal at a downtown law firm, the student at Stuyvesant High School walking home through dust clouds, or the retired electrician like James Ryan who returned to rewire the PATH station two days after the towers fell.
Ryan was later diagnosed with pancreatic cancer. Leslie Lane, who worked in the World Financial Center, was diagnosed with thymus cancer — a disease she calls unlikely given that she never smoked or drank. Both said they were told repeatedly that the air was safe to breathe. Neither considers their cancer coincidence.
The system, however, is not keeping pace with the reality on the ground. Only about 15% of exposed civilians are enrolled in the WTC Health Program, according to lawyer Michael Barasch, whose firm represents thousands of enrolled clients. That means roughly eight in ten people who inhaled toxic dust at or near Ground Zero are not in the system at all.
Who Wins, Who Loses
Who wins from this? Not the survivors, frankly. The data confirms what many already knew: the toxic exposure at Ground Zero causes cancers that strike later, strike rarer, and strike across demographics that traditional risk models don’t capture. Men get breast cancer. Young students getillnesses typically seen in older populations. Thymus and neuroendocrine tumors — the kind that make oncologists pause — are now on the books in numbers large enough to track.
The government, through the WTC Health Program, is losing in the only way that matters: it is losing people. Every day, roughly two program members die. Every 50 minutes, a new certification is added. The program is a moving target that is simultaneously growing faster and covering fewer of the people it was designed to protect.
Who loses is clearer. Civilians who were exposed and never enrolled are the biggest losers. They cannot access cancer treatment through the program. They cannot get respiratory care, mental health services, or monitoring for the 69 different cancers the program recognizes as linked to 9/11 toxins. They are, in effect, invisible to the system — until they die.
The Death Toll Will Keep Climbing
At least 9,425 people have died from post-9/11-related illnesses through June of this year, more than triple the 2,977 who died on September 11, 2001. That number is almost certainly an underestimate. People are still being diagnosed. People are still enrolling. The program has 145,275 active members, and 67% of them carry at least one cancer certification — far above the roughly 40% lifetime cancer rate for Americans overall.
The demographic reality is working against everyone involved. Most survivors and responders are now in their late 50s, 60s, or 70s. Aging increases cancer risk regardless of exposure. But the data from the CDC and the National Cancer Institute suggests these are not ordinary cancers — they are the kind linked to the specific cocktail of toxins released when the towers fell.
What Happens Next
The 25th anniversary of the attacks arrives at a moment when the crisis has quietly shifted from a first-responder story to a broader public health emergency. That shift should force a reckoning with how the program defines eligibility, how it reaches the civilians who were never counted, and how it funds long-term care for a population that keeps growing.
Barasch’s point is straightforward and hard to argue with: early detection is the difference between life and death. But early detection requires enrollment. And enrollment requires people to know the program exists, to believe they qualify, and to navigate a system that was never designed for someone who lived three blocks from the Twin Towers rather than worked in it.
The statistics are no longer a warning. They are a record. And the record says the 9/11 health crisis is not behind us — it is still accelerating, and it is reaching people the system was never built to help.